Our latest thinking, insights and company news

Never miss an update, subscribe today.

RJW&partners will only use your personal information to administer your account and provide the products and services you request. You can unsubscribe at any time, to do so please review our Privacy Policy. By clicking subscribe, you consent to allow RJW&partners to store and process your personal information.

Aug 11
9 min

Risk-Sharing Agreements: a fancy way to discount?

Risk-Sharing Agreements have been hailed as a solution to attain access for innovative medicines with limited evidence packages or high...

48 views

Jun 14
7 min

One step forward, two steps back: Is the UK driving away pharmaceutical manufacturers?

The UK voluntary scheme payback rate on NHS sales of branded medicines was set to 26.5%. Is the UK driving away pharmaceutical companies?

52 views

Mar 21
8 min

Why early consideration of Market Access means a better night’s sleep

Why early P&MA planning is always a good investment

151 views

Dec 5, 2022
1 min

NICE Scientific Advice – an updated process from 1st December 2022

NICE updated the process for providing scientific advice on December 2022, We describe these changes.

152 views

Oct 31, 2022
13 min

The Emergence of HTA in the Middle East and North Africa Region

As more stakeholders from the healthcare sector embrace evidence-based policy development and decision-making, we take a look at the latest

74 views

Apr 14, 2022
9 min

Will US payers cope with the influx of high-cost cell and gene therapies over the coming years?

A summary of some of the challenges and solutions associated with cell and gene therapy coverage and pricing in the US

366 views

Our latest thinking, insights and company news

Never miss an update, subscribe today.

​